chartexchange

BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026

GlobeNewswire Inc. | Nov 9, 2026 4:18 PM EST

SUNNYVALE, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ:BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the third quarter of 2026 by conference call on Thursday, November 12, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session.

Read original article